Preview Mode Links will not work in preview mode

Evidence and experts to help you understand today’s public health news—and what it means for tomorrow.

Jun 1, 2020

Dr. Julie Gerberding was director of the CDC during the 2003 SARS outbreak and lessons learned from that response are now informing her work overseeing some 65,000 employees around the world as executive vice president of Merck. Gerberding talks with Dr. Josh Sharfstein about the US’s response, how Merck is keeping things moving, why emerging infectious diseases may be a new normal, and how the pandemic is contributing to the threat of antimicrobial resistance.